Oral nutritional supplements for the increase of oral caloric intake after gastrectomy: a single-arm prospective study
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000045645
- Lead Sponsor
- iigata University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Not provided
(1) Patients with carcinoma in the remnant stomach after gastrectomy (2) Patients with active multiple cancers (3) Patients with serious comorbidities (interstitial pneumonia or pulmonary fibrosis, difficult-to-control diabetes or hypertension, heart failure, renal failure, liver cirrhosis, liver failure, etc.) (4) Patients with allergies to oral nutritional supplements (5) Patients on warfarin medication (6) Patients with lactose intolerance (7) Patients with medical electrical devices such as pacemakers and implantable cardiac defibrillators (8) Patients with motor disorders of the upper or lower limbs due to orthopedic or neurological diseases, etc. (9) Patients who are judged unsuitable for the study by the principal investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients who took an average of 200 kcal/day or more of oral nutrition
- Secondary Outcome Measures
Name Time Method Weight loss rate, fat loss rate, and gluten loss rate 3 months after surgery Weight loss rate, fat-free weight loss rate, and gluten reduction rate 1 year after surgery Evaluation of various types of nutrition (TP, Alb, T-Chol, Rine pellet count, etc.) Adverse events